Is INGR a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Corn costs pass through, so revenue and profit move separately, with revenue (ttm) at ~$7.2B. The bear case rests on the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Analysts covering it are spread from $108.00 to $150.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $108.00, +2.7% from the $105.20 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Corn costs pass through, so revenue and profit move separately. Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. The most optimistic analyst target on INGR is $150.00, +42.6% from the $105.20 price. That figure is only reachable if this thesis works close to its best case.

The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Funding Tate & Lyle takes net debt from roughly ~$0.8 billion today to about ~3.0x EBITDA at completion, and with closing not expected until the second half of 2027 there is a long window of antitrust review, integration planning and carrying cost before any synergy shows up. Second quarter financing costs jumped to ~$55 million mostly because of ~$47 million in hedging losses on the sterling consideration, so the currency exposure is already live even though the deal is not. Latin America supplies roughly a third of sales and carries Mexican peso translation risk plus what management called a more challenging demand environment. High fructose corn syrup consumption in North America is in slow secular decline, which the specialty growth has to outrun rather than merely offset. The most pessimistic published target is $108.00, +2.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Ingredion turns corn and other crops into starches, sweeteners and texturizing ingredients sold to food, beverage and industrial manufacturers worldwide.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Corn costs pass through, so revenue and profit move separately) stalling in the reported numbers rather than in the narrative, the risk above (the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It processes corn and other crops into starches, sweeteners, texturizers and nutrition ingredients that go into packaged food, drinks, paper, adhesives and pharmaceuticals. Very little of it reaches a shelf under the Ingredion name. Customers are food and beverage manufacturers who buy on contract.

Net sales were ~$3,642 million against ~$3,646 million a year earlier, but cost of sales rose ~4% on higher manufacturing costs and the Argo thermal event, pushing gross margin from ~26% to ~23%. Restructuring charges of ~$56 million tied to the Cabo, Brazil closure and ~$47 million of acquisition hedging losses did the rest. Net income attributable to Ingredion fell to ~$256 million from ~$393 million.

Less than the raw material intensity suggests. Core sweetener and starch contracts pass net corn costs through to customers, so corn moves the revenue line in both directions without much effect on gross profit. What corn does influence is working capital and hedging, and the company runs commodity cash flow hedges against it.